Anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody cixutumumab (cix) plus mTOR inhibitor temsirolimus (tem) in metastatic castration-resistant prostate cancer (mCRPC): Results of a phase I pilot study Meeting Abstract


Authors: Rathkopf, D. E.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Borwick, L. S.; Momen, L.; Curley, T.; Arauz, G.; Larson, S. M.; Fleisher, M.; Rosen, N.; Scher, H. I.
Abstract Title: Anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody cixutumumab (cix) plus mTOR inhibitor temsirolimus (tem) in metastatic castration-resistant prostate cancer (mCRPC): Results of a phase I pilot study
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880303784
DOI: 10.1200/jco.2011.29.15_suppl.e15081
PROVIDER: wos
Notes: Meeting Abstract: e15081 -- Source: Wos
Altmetric Score
MSK Authors
  1. Neal Rosen
    356 Rosen
  2. Susan Slovin
    184 Slovin
  3. Michael Morris
    274 Morris
  4. Gabrielle Arauz
    7 Arauz
  5. Dana Elizabeth Rathkopf
    142 Rathkopf
  6. Steven M Larson
    762 Larson
  7. Martin Fleisher
    236 Fleisher
  8. Howard Scher
    816 Scher
  9. Daniel C Danila
    82 Danila
  10. Lamia Farrah Sun
    6 Sun